Clinical trial
Sequential Combination of Chemotherapy With Gemcitabine/Oxaliplatin and Photodynamic Therapy in Advanced Cholangiocarcinoma
NCT00713687 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sequential Combination of Chemotherapy With Gemcitabine/Oxaliplatin and Photodynamic Therapy in Advanced Cholangiocarcinoma
- Lead sponsor
- Technical University of Munich
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- August 31, 2008
- Completion date
- December 31, 2011
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.